GMI

Bisphosphonates used for osteoporosis in patients with cystic fibrosis increases bone mineral density without increasing bone quality/strength, while causing bone pain and flu-like symptoms.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *